In March 2023 the Anti-Doping Agency of Kenya (ADAK) reported an anti-doping rule violation against the Athlete Isgah Cheruto after her sample tested positive for the prohibited substances 19-norandrosterone an 19-noretiocholanolone (Nandrolone).
Following notification a provisional suspension was ordered. The Athlete filed a statement in her defence and the case was referred to the Kenya Sports Disputes Tribunal.
The Athlete accepted the test result and denied the intentional use of the substance. She stated that in 2022 she suffered from several medical conditions and had online purchased and used the medication Norethisterone as treatment.
ADAK contended that the Athlete failed to demonstrate with evidence that the violation was not intentional, nor how the substance had entered her system. It deemed that the Athlete's use of the medication Norethisterone could not explain the presence of Nandrolone in her sample.
The Panel finds that the presence of a prohibited substance has been established in the Athlete's sample and accordingly that she committed an anti-doping rule violation.
The Panel agrees that the Athlete failed to demonstrate with corroboration evidence that her violation was not intentional, nor how the prohibited substance had entered her system.
Therefore the Tribunal decides on 30 May 2024 to impose a 4 year period of ineligibility on the Athlete, starting on the date of the provisional suspension, i.e. on 18 April 2024.
